Stephen Kanes, Chief Medical Officer at Sage Therapeutics, Inc. (SAGE), sold 6,000 shares at $42.05 ($252K) on 2015-02-25, disclosed to the SEC on 2015-02-27.
Open-market sale of $252k SAGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2016-04-21 | $798K | — | Filing → |
| SAGE | SELL | 2015-09-29 | $279K | — | Filing → |
| SAGE | SELL | 2015-09-01 | $637K | — | Filing → |